Siddhartha Pharmaceuticals to Issue IPO, Appoints Siddhartha Capital as Issue Manager

Siddhartha Pharmaceuticals Limited is set to launch its Initial Public Offering (IPO), appointing Siddhartha Capital Limited as the issue and sales manager. The company plans to issue 10 lakh units of shares to the public at a face value of Rs. 100 per share. A formal agreement between the two parties was signed on Magh 27, 2082, in Kathmandu.

Established in 1987 and in production since 1990, Siddhartha Pharmaceuticals has been contributing to Nepal’s healthcare sector by manufacturing quality, safe, and affordable medicines. The company operates a modern production facility in Tilottama-15, Rupandehi, which was built in compliance with WHO-GMP standards and is equipped with advanced, world-class technology to ensure the production of high-quality pharmaceutical products.